Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 51.84% vs 43.01% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 25.00% vs 285.71% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 26.55% vs 321.43% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 60.00% vs 150.00% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Eiko Lifescience With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 5.79% vs -8.67% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 51.84% vs 43.01% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 3.05% vs 0.77% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 25.00% vs 285.71% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 16.06% vs -15.35% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 26.55% vs 321.43% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 23.08% vs 8.33% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 60.00% vs 150.00% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025